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Abstract
Four new Standard Reference Materials (SRMs) have been developed to assist in the quality 
assurance of chemical contaminant measurements required for human biomonitoring studies, SRM 
1953 Organic Contaminants in Non-Fortified Human Milk, SRM 1954 Organic Contaminants in 
Fortified Human Milk, SRM 1957 Organic Contaminants in Non-Fortified Human Serum, and 
SRM 1958 Organic Contaminants in Fortified Human Serum. These materials were developed as 
part of a collaboration between the National Institute of Standards and Technology (NIST) and the 
Centers for Disease Control and Prevention (CDC) with both agencies contributing data used in 
the certification of mass fraction values for a wide range of organic contaminants including 
polychlorinated biphenyl (PCB) congeners, chlorinated pesticides, polybrominated diphenyl ether 
(PBDE) congeners, and polychlorinated dibenzo-p-dioxin (PCDD) and dibenzofuran (PCDF) 
congeners. The certified mass fractions of the organic contaminants in unfortified samples, SRM 
1953 and SRM 1957, ranged from 12 ng/kg to 2200 ng/kg with the exception of 4,4′-DDE in 
SRM 1953 at 7400 ng/kg with expanded uncertainties generally <14 %. This agreement suggests 
that there were no significant biases existing among the multiple methods used for analysis.
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Introduction
Data for contaminants in the human population from biomonitoring studies based on 
analysis of human serum, milk, adipose tissue, urine, and/or other tissues or fluids [1–8, to 
cite a few] abound in the literature. These representative studies have been done in the U.S. 
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[1, 2], Canada [3], Belgium [4], Japan [5], Korea [6], Sweden [7], and the Ukraine [8]. The 
published data are often used by risk assessors to evaluate potential biological effects from 
the amount of chemicals absorbed into the human body and to identify long-term trends in 
the population [9]. To compare the data among studies conducted both nationally and 
internationally, it is important that the accuracy of biomonitoring data be supported by 
appropriate quality control samples, including the use of reference materials and 
participation in interlaboratory comparison studies [10]. Risk assessors need to have 
confidence in the analytical methods that were used to generate the data as well as in the 
sampling strategy that was used to obtain the samples [10]. As part of the National Health 
and Nutrition Examination Survey (NHANES) and other biomonitoring programs, the 
Centers for Disease Control and Prevention (CDC) uses an extensive quality assurance 
program with as many as 60 % quality control samples included in their analyses [11].
Certified Reference Materials (CRMs), of which Standard Reference Materials (SRMs) are a 
subset produced by the National Institute of Standards and Technology (NIST), are valuable 
tools in developing and validating analytical methods to improve quality assurance 
standards. NIST developed the first serum-matrix SRM for the measurement of organic 
contaminants in 1985. This material, SRM 1589 Polychlorinated Biphenyls (as Aroclor 
1260) in Human Serum [12], was prepared by fortifying human serum with Aroclor 1260 
prior to freeze-drying. In 2000 SRM 1589 was replaced with SRM 1589a PCBs, Pesticides 
and Dioxin/Furans in Human Serum which was prepared using a serum pool collected in 
1996 [13] that had been prescreened and found to contain measurable levels of the 
contaminants of interest. SRM 1589a was not fortified, containing only natural levels of the 
organic contaminants with mass fractions value assigned for selected poly-chlorinated 
biphenyl (PCB) congeners, chlorinated pesticides, polychlorinated dibenzo-p-dioxin 
(PCDD) congeners, and polychlorinated dibenzofuran (PCDF) congeners. In 2006 the 
Certificate of Analysis for SRM 1589a was updated to increase the number of PCB 
congeners and chlorinated pesticides that were value assigned and also to add mass fraction 
values for selected polybrominated diphenyl ether (PBDE) congeners [14, 15]. This material 
found widespread use as a control material for human biomonitoring programs such as the 
NHANES and is no longer available.
Another matrix of interest in monitoring the exposure of the human population to 
environmental contaminants is human milk. Human milk is an important exposure route for 
organic contaminants to the nursing infant [5, 8, 16]. Human milk has approximately 10 
times the lipid content compared to human serum; therefore, on a wet-mass basis, serum is 
not a good surrogate for milk. Some studies, such as Inoue et al. [5] and Hites [16], suggest 
that similar values of lipophilic contaminants are obtained from serum and breast milk if the 
measurements are normalized to lipid content. However, the calculation of total lipid varies 
among laboratories with gravimetric lipid determinations being the traditional method of 
choice, although some laboratories now use enzymatic analysis of lipid species in serum 
followed by summation [17]. The differences in lipid content and methods of lipid 
determinations suggest that quality control samples should match the matrix of interest.
NIST and the CDC Division of Laboratory Sciences have collaborated to develop four new 
SRMs to meet the expanding needs for the measurement of organic contaminants in human 
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serum and milk. The timing was based not only on the impending depletion of the supply of 
SRM 1589a but also on the growing need for an SRM representative of more contemporary 
serum contaminant levels. The goals of the NIST/CDC collaboration were to produce human 
serum and milk SRMs at current contaminant levels and at elevated levels and to produce a 
sufficient supply to be available for 10 years. To accomplish these goals, collections of 
serum (total of 200 L) and milk (total of 100 L) were obtained from blood banks and milk 
banks, respectively, located around the U.S., combined, and mixed. For each matrix (serum 
and milk), one SRM is a natural level (SRM 1953 Organic Contaminants in Non-Fortified 
Human Milk [18] and SRM 1957 Organic Contaminants in Non-Fortified Human Serum 
[19]), and the other SRM (SRM 1954 Organic Contaminants in Fortified Human Milk [20] 
and SRM 1958 Organic Contaminants in Fortified Serum [21]) is from the same serum or 
milk pool to which 169 organic contaminants have been added (See Table S1). The fortified 
serum and milk SRMs were prepared to represent contaminant concentrations that are 
approximately ten times higher than the median concentrations found in the U.S. population 
during the 2003 NHANES study [2].
The preparation and characterization of these four SRMs for PCBs, chlorinated pesticides, 
PBDEs, PCDDs, and PCDFs are described in this paper. The assignment of mass fraction 
values for selected contaminants in these materials involved the combination of results from 
gas chromatography/mass spectrometry (GC/MS) analyses by NIST and CDC, as well as 
results from four laboratories, AXYS Analytical Services (Sidney, B.C., Canada), National 
Institute of Public Health of Québec (Québec, Canada), Stockholm University (Stockholm, 
Sweden), and University of Liege (Liege, Belgium), which participated in an interlaboratory 
study using the four SRMs as unknown samples with each laboratory using its normal 
methods of analysis.
Experimental
Source and preparation of serum and milk SRMs
Plasma used for SRM 1957 and SRM 1958 was acquired in 2004 from various blood banks 
located around the U.S.: Wilmington and Greenville, NC (10 %); Jacksonville and Orlando, 
FL (8 %); Jonesboro, AR (12 %); Flagstaff, AZ (15 %); Gallup and Albuquerque, NM 
(20 %); Memphis, TN (12 %); Portland, ME (16 %); and Carbondale, IL (7 %). Following 
the precipitation of fibrin and filtration to ensure better homogeneity of the sample, the 
serum was pooled (approximately 200 L total) and stored at 4 °C. The pool was split into 
two batches of 100 L each for production of SRM 1957 and SRM 1958. For SRM 1958 
approximately 710 mL of a methanol solution containing 169 compounds (Table S1) at 
varying mass/volume (see below) was added to the 100 L batch of serum, which was then 
stirred for 4 h. Using a calibrated automatic pipetter, 10.7 mL aliquots of serum were 
dispensed into 30 mL amber glass vials, and the samples were lyophilized until a stable 
vacuum and temperature were achieved. Approximately 10,000 vials of each SRM were 
prepared, and a sales unit of SRM 1957 and SRM 1958 consists of 5 vials of freeze-dried 
serum. Before use, the serum in each vial must be reconstituted with 10.7 mL of distilled or 
HPLC-grade water.
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The pasteurized milk used for SRM 1953 and SRM 1954 was acquired in 2006 from six 
milk banks located around the U.S: Florida (4 %), North Carolina (6 %), Iowa (6 %), 
Delaware (7 %), California (12 %), and Texas (65 %). The SRMs were prepared from milk 
that had either reached its expiration date or was considered “research milk” that could not 
be fed to babies. (Research milk includes milk that has too low a caloric content or tested 
positive for bacteria prior to pasteurization.) The milk was pooled (approximately 100 L 
total) and was stored at 4 °C. The pool was split into two batches of 50 L each for 
production of SRM 1953 and SRM 1954. For SRM 1954 approximately 355 mL of a 
methanol solution containing 169 compounds at varying concentrations (the same solution 
as added to SRM 1958, see below for more information) was added to the 50 L batch of 
milk, which was then stirred for 4 h. Using a calibrated automatic pipetter, 5-mL aliquots of 
milk were dispensed into 10 mL amber glass vials which were then stored at −20 °C. 
Approximately 5,000 vials of each milk SRM were prepared, and a sales unit of SRM 1953 
and SRM 1954 consists of 5 vials of frozen milk.
The methanol spiking solution was prepared by Cambridge Isotope Labs (Andover, MA) 
and contained 169 compounds at the indicated mass concentration: 38 non and mono ortho-
PCBs (50 pg/mL to 500 pg/mL), 4 non-ortho-PCBs (0.4 pg/mL to 0.8 pg/mL), 22 
chlorinated pesticides including 6 toxaphene congeners (500 pg/mL), 17 PBDEs (500 pg/
mL), polybrominated biphenyl (PBB) 153 (500 pg/mL), hexabromocyclododecanes (500 pg/
mL), 1,2-bis(2,4,6-tribromophenyloxy)ethane (500 pg/mL), hexabromobenzene (500 pg/
mL), decabromodiphenylethane (500 pg/mL), 17 PCDDs/PCDFs (0.1 pg/mL to 2.4 pg/mL), 
7 polybrominated dibenzodioxins, 10 polybrominated dibenzofurans, and 8 chlorobromo 
dibenzodioxins and dibenzofurans (0.05 pg/mL), 9 polychlorinated naphthalenes (PCNs) (1 
pg/mL), 12 halogenated phenolic compounds, 5 hydroxylated PCBs (500 pg/mL), and 8 
other persistent organochlorine compounds (500 pg/mL) including 4 chlorobenzenes, 
octachlorostyrene, pentachloronitrobenzene, hexachlorocyclopentadiene, and 
hexachloro-1,3-butadiene. The individual compounds in the spiking solution are listed in 
Table S1.
Analytical methods—The analytical methods used are described in detail in the 
supplementary information (see Electronic Supplementary Material Figure S1) with a 
summary here. Multiple methods of analysis were used at NIST for the determination of the 
PCBs, pesticides, and PBDEs in both the milk and serum, and an additional method was 
developed for the determination of the hydroxylated compounds in serum only (see 
Supplemental information). The first method was used for the homogeneity study, analyzing 
10 bottles using a liquid-liquid extraction with n-hexane: methyl-tert-butyl ether, a sample 
clean-up using concentrated sulfuric acid followed by silica solid-phase extraction (SPE) 
fractionation. The final analysis used gas chromatography/mass spectrometry (GC/MS) 
operated both in the electron ionization (EI) and negative ion chemical ionization (NICI) 
mode with on-column injections. The GC column used for the EI analysis was a non-polar 
proprietary phase (Agilent Technologies, Wilmington, DE) while the column used for the 
NICI analysis was a 50 % (mole fraction) phenyl-substituted methylpolysiloxane phase.
The second method at NIST used focused microwave extraction with 3 mL of 20 % (volume 
fraction) dichloromethane in hexane as described by Keller et al. [22]. An acidified silica 
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column clean-up followed by an alumina column (5 % deactivated) clean-up was used with 
final analysis using GC/MS in the EI mode with a 5 % phenyl-substituted 
methylpolysiloxane phase. The injections used a programmable temperature vaporization 
(PTV) inlet. The extracts were also injected on-column using a shorter column (10 m 
compared to 30 m; note that the short column was used to reduce degradation of the higher 
brominated PBDEs on-column) connected to the NICI source in the GC/MS.
The methods used by CDC are described in more detail in Patterson and Turner [23] and 
Sjödin et al. [24, 25]. Gas chromatography/high resolution mass spectrometry (GC/HRMS) 
with mass resolution of 10,000 and equipped with a 5 % phenyl-substituted 
methylpolysiloxane phase was used.
The laboratories participating in the interlaboratory study employed the methods commonly 
used in their laboratories for the determination of these compounds in serum and milk. The 
methods used by University of Liege are described in more detail in Focant et al. [26].
Results and discussion
Since the development of the first natural-matrix SRMs for organic contaminants at NIST 
over 30 years ago, the assignment of certified mass fraction values have been based on the 
combination of results from two or more independent methods [28]. Currently NIST SRMs 
for chemical composition are assigned mass fraction values designated certified, reference, 
or information values based on the number and independence of the analytical methods 
used, source of the results, and degree of confidence in the accuracy of the assigned value 
[27, 28].
As described above, results from two to five methods of analysis were used to assign 
certified and reference mass fraction values for the milk and serum materials. For the PCBs, 
chlorinated pesticides, and PBDEs, the assigned values were based on results from two or 
three NIST methods, the CDC method, and the interlaboratory study. The various methods 
included different extraction procedures, clean up procedures, and GC/MS or GC/HRMS 
with different stationary phase columns. The PCDD/PCDF congeners were assigned 
reference values using results from only the CDC method and the interlaboratory study of 
results from two laboratories. Similarly the reference values for the hydroxylated 
compounds were assigned based on results from LC/MS/MS (NIST method 3, see 
Supplemental information) and the interlaboratory study.
The results from each of the five methods are summarized in Electronic Supplementary 
Material Tables S2 through S5 for SRM 1953, SRM 1954, SRM 1957, and SRM 1958, 
respectively. The results of the different methods were combined as weighted means [29] to 
assign the certified and reference mass fraction values. The resulting certified, reference, and 
information mass fraction values are summarized in Tables 1, 2, 3, and 4 for the PCB 
congeners, pesticides, PBDE congeners, and PCDD and PCDF congeners, respectively.
For each of the materials, the homogeneity of the PCBs, pesticides, and PBDEs was 
assessed at NIST using method 1 described above. An analysis of variance did not show 
inhomogeneity for a 2.5 g sample of milk or for a 5 g sample of serum [18–21]. Other 
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analytes were treated as though they were homogeneously distributed in the material 
although homogeneity was not assessed. The long-term stability of the freeze-dried serum 
materials has been demonstrated for SRM 1589a in which the PCBs and pesticides have 
been shown to be stable over an 8 year period [15]. Stability assessments are conducted 
regularly on the freeze-dried serum and frozen milk samples primarily through their use as 
control samples for other analyses.
For the non-fortified serum and milk, the certified mass fractions of the organic 
contaminants ranged from 12 ng/kg to 2200 ng/kg (excluding 4,4′-DDE at 7400 ng/kg) with 
expanded relative uncertainties from approximately 1 % to 14 %, with the exception of PCB 
138 in SRM 1957 for which the expanded relative uncertainty is 24 %. Of the 46 certified 
values in the non-fortified milk and serum SRMs, 26 had relative uncertainties less than 5 % 
and only 8 had relative uncertainties greater than 10 %. For the fortified serum and milk, the 
certified mass fractions ranged from 400 ng/kg to 2600 ng/kg (excluding 4,4′-DDE at 8200 
ng/kg) with expanded relative uncertainties from approximately 1 % to 15 %. For the 128 
certified values in the fortified milk and serum SRMs, 111 had relative uncertainties less 
than 10 % with 65 having relative uncertainties less than 5 %. The agreement of the results 
from the different methods for both the non-fortified and the fortified serum and milk, based 
on the uncertainties associated with the certified values, are consistent over a wide range in 
mass fractions (two orders of magnitude) suggesting that no significant biases exist among 
the methods using different extraction, isolation, and GC/MS columns.
For the natural (non-fortified) serum and milk SRMs, the wet-mass based contaminant levels 
are higher in the milk compared to the serum due to the higher lipid content of the milk. The 
milk sample contains a mass fraction of 3.21 %± 0.33 % total extractable lipid as determined 
by a gravimetric drying step following extraction. Despite using research milk (milk that has 
too low a caloric content to be fed to infants), the lipid content of the SRM is similar to that 
found in breast milk from biomonitoring studies [8, 25]. The serum sample contains 0.471 %
±0.065 % lipid for SRM 1957 and 0.406 %±0.036 % lipid for SRM 1958 as determined by 
three methods: a gravimetric drying, the Bligh and Dyer method, and an enzymatic analysis 
[17]. Comparing the contaminant levels on a lipid-basis, the non-fortified milk sample (SRM 
1953) has higher values of the tetra-, penta-, and some hexachlorinated PCB congeners 
while the non-fortified serum (SRM 1957) has equivalent or slightly higher mass fractions of 
the higher chlorinated PCB congeners, particularly PCB 180 (see Electronic Supplementary 
Material Figure S2). PCB 153/132 is the predominant PCB congener in both samples 
contributing almost 30 % of the total PCB composition (see Figure S2). PCB 153 and PCB 
132 are separable on a number of GC columns; however, since a number of the methods for 
the certification of these SRMS relied on a 5 % phenyl methylpolysiloxane phase which 
does not separate PCB 132 from PCB 153, the certified value is for the combined PCB 
153/132. On a lipid basis the non-fortified milk sample has higher mass fractions for most of 
the chlorinated pesticides and some of the PBDE congeners, particularly PBDE 100 and 
PBDE 153. For the PBDE congeners, PBDE 47 is the most abundant in both the milk and 
serum samples, contributing approximately 50 % of the total PBDE content (see Electronic 
Supplementary Material Figure S3). In comparing these samples, however, note that the milk 
and serum pools were not collected from the same individuals.
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The goal in preparing the fortified serum SRM was to provide a material in which 
compounds not detectable in the average natural level found in the US would be present at 
detectable levels. These compounds may be present at higher concentrations in a sub-
segment of the population with higher exposure; therefore reference materials with 
detectable levels are needed. Based on the certified values for the two serum SRMs, the 
PCB, pesticide, and PBDE mass fractions in the fortified material range from approximately 
10 to 30 times the mass fractions in the non-fortified (natural) material with the exception of 
the highest level contaminants such as 4,4′-DDE and PBDE 47 which are only 1 to 3 times 
greater in SRM 1958. The two milk SRMs differ by only a factor of 2 to 4 in mass fraction 
levels for many of the pesticides and PBDEs (the predominant compounds), whereas the 
PCBs generally differ by a factor of 10 to 20. The fortified materials, SRM 1954 and SRM 
1958, were both spiked with the same spiking solution (see Table S1). When the measured 
mass fraction differences between the fortified and non-fortified milk samples are compared 
to the difference between the fortified and non-fortified serum samples, the differences are 
similar and consistent. Based on the homogeneity analyses, the spiking solution was well 
mixed within the samples prior to bottling.
In addition to the compounds characterized in this study, SRM 1954 and SRM 1958 were 
fortified with compounds anticipated to be of interest in future monitoring studies including 
additional brominated flame retardants, polybrominated dibenzodioxins, polybrominated 
dibenzofurans, mixed chlorinated and brominated dibenzodioxins and dibenzofurans, 
polychlorinated naphthalenes, and hydroxylated PCBs (see Table S1). As new flame 
retardants are introduced into products, they will need to be monitored in human samples, as 
well as the combustion products from the incineration of the products, which produce the 
brominated and mixed chlorinated/brominated dioxins and furans. Hydroxylated metabolites 
of the contaminants, such as the hydroxylated PCBs are toxicologically more active than 
their parent compounds, although found at lower levels in the serum and milk. With these 
additional compounds added to the serum and milk pools, these SRMs will be valuable for 
future method development. The serum materials have also been characterized for selected 
perfluorinated compounds (PFCs) as described in Keller et al. [30]. (PFCs were not included 
in the spiking solution.) Nutrient elements, including calcium, copper, iron, magnesium, 
manganese, phosphorous, potassium, sodium, and zinc, and the toxic metal mercury, were 
determined in the milk samples, and the results are provided on the Certificates on Analysis 
as reference mass fractions [18, 20, 31].
SRM 1957 was developed in part to address the need for a serum material representing more 
contemporary contaminant levels in the U.S. population than the previous material, SRM 
1589a. Using biomonitoring data, Sjödin et al. [32] demonstrated the decrease in legacy 
chemicals (no longer in use in the U.S.) such as PCBs and the increase in more recently used 
chemicals such as PBDEs in serum collected from 1984 to 2002. Comparison of the mass 
fractions of contaminants in SRM 1589a (collected in 1996) and SRM 1957 (collected in 
2004) indicates similar trends as shown in Fig. 1. For example, PCB congener values in 
SRM 1957 are generally 10 to 15 times lower than in SRM 1589a. Similarly the mass 
fraction of 4,4′-DDE was 12 times lower in SRM 1957 compared to SRM 1589a. For the 
PCDD/PCDF congeners (not shown in Fig. 1), the mass fractions were typically a factor of 
four lower in SRM 1957 compared to SRM 1589a, e.g., 1,2,3,6,7,8-hexaCDD (416 pg/kg
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±12 pg/kg vs. 84.7 pg/kg±8.1 pg/kg). For the flame retardants such as PBDEs, the values in 
SRM 1957 have increased typically by a factor of two compared to SRM 1589a. Likewise 
for PFCs, another group of compounds used recently, mass fractions were a factor of 5 and 
10 higher in SRM 1957 compared to SRM 1589a for the predominant PFCs [30]. In making 
the comparison of SRM 1589a to SRM 1957, however, it should be noted that SRM 1589a 
was prepared from serum collected from donor units that had been prescreened at NIST for 
the PCB content, and the units with high PCB content were selected (all coming from the 
Chicago area, preferably from donors who ate fish caught in the Great Lakes), whereas SRM 
1957 was prepared from random donor units (i.e., no prescreening) from multiple collection 
sites.
Conclusion
These new human serum and milk SRMs represent human samples commonly used for the 
monitoring of environmental contaminants. SRMs 1953 and 1954 are the first human milk 
certified reference materials available worldwide that have been characterized for organic 
contaminants. It should be noted that although there are some environmental contaminants 
present in human milk, the nutritional benefits of breastfeeding to the infant likely outweigh 
any harmful effects (for example, see http://www.cdc.gov/breastfeeding/). SRM 1957 
represents the most extensively characterized natural human serum certified reference 
material for persistent organic contaminants available from any source worldwide. The 
fortified milk and serum SRMs, with certified and reference values for 91 and 92 PCBs, 
pesticides, PBDEs, and dioxins/furans, respectively, are valuable reference materials for 
contaminants currently monitored, as well as for contaminant classes that may be monitored 
extensively in the future. These materials will find extensive use in the biomonitoring 
community and will aid in the comparison of data among biomonitoring studies performed 
in different years and by different laboratories.
Supplementary Material
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Comparison of mass fractions for legacy chemicals (PCBs and 4,4′-DDE) and chemicals 
used more recently (PBDEs and PFCs) in serum collected in 1996 (SRM 1589a) and serum 
collected in 2004 (SRM 1957). Error bars represent the expanded uncertainties
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Table 1
Certified, Reference, and Information mass fractions (ng/kg milk or reconstituted serum) of selected PCB 
congeners in SRM 1953 organic contaminants in non-fortified human milk, SRM 1954 organic contaminants 
in fortified human milk, SRM 1957 organic contaminants in non-fortified human serum, and SRM 1958 
organic contaminants in fortified human serum
PCB congenera SRM 1953 SRM 1954 SRM 1957 SRM 1958
PCB 18 355±76b 4.5±0.8c 407±14b
PCB 28 62.8±1.2b 519±23b 8.6±1.1c 402±12b
PCB 44 417±31b 408±21b
PCB 49 426±8b 414±15b
PCB 52 7.65±0.23c 424±46b 401±14b
PCB 66 32.8±1.1b 429±39b 5.6±1.7c 414±6b
PCB 74 149±2b 562±8b 13.8±0.1b 414±46b
PCB 77 0.673±0.047c 2.71±0.14c
PCB 81 0.092±0.006c 0.630±0.028c
PCB 87 455±52b 396±23b
PCB 99 139±5b 552±8b 11.6±0.6c 385±28b
PCB 101 441±29b 409±27b
PCB 105 47.5±6.7b 478±6b 419±31b
PCB 110 12.3±0.4b 459±36b 397±26b
PCB 114 90.5±7.4c 46.6±8.4b
PCB 118 213±4 594±34 18.9±1.2 412±35b
PCB 123 67.9±3.1c 52.5±4.8b
PCB 126 0.79±0.15b 10.4±2.5b 7.8±1.1b
PCB 128 400±29b 420±17b
PCB 138 319±27b 646±17b 36.9±9.0b 473±54b
PCB 146 55.6±0.8b 495±25b 7.17±0.26c 378±26b
PCB 149 7.40±0.60c 409±3b 373±22b
PCB 151 418±11b 381±18b
PCB 153 478±6b 980±6b 58.2±0.9b 457±36b
PCB 156 60.7±4.0b 505±7b 8.24±0.57b 418±19b
PCB 157 14.7±0.6b 467±37b 420±42b
PCB 158 408±8b 365±48b
PCB 167 15.9±2.2b 467±59b 403±26b
PCB 169 0.216±0.020b 9.3±2.0b 8.10±0.33b
PCB 170 100±18b 505±69b 16.2±2.0b 422±23b
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PCB congenera SRM 1953 SRM 1954 SRM 1957 SRM 1958
PCB 172 14.8±0.6b 443±34b 395±28b
PCB 177 23.7±1.2b 450±6b 392±9b
PCB 178 22.2±0.5b 449±15b 3.61±0.32c 386±15b
PCB 180 234±8b 678±58b 459±49b
PCB 180/193 54.5±0.5b
PCB 183 37.1±5.2b 446±22b 5.77±0.35c 407±36b
PCB 187 96±17b 517±28b 15.5±0.5b 411±38b
PCB 189 432±39b 402±31b
PCB 194 50±16b 484±6b 11.9±0.3b 387±20b
PCB 195 11.9±1.6c 459±19b 385±25b
PCB 196 397±2b
PCB 196/203 870±31b 10.9±0.7c
PCB 199 469±17b 11.2±0.8c 362±15b
PCB 201 397±7b
PCB 203 398±49b
PCB 206 463±12b 6.98±0.37c 366±8b
PCB 209 441±26b 3.33±0.59c 338±16b
a
PCB congeners are numbered according to the scheme proposed by Ballschmiter and Zell [33] and later revised by Schulte and Malisch [34] to 
conform with IUPAC rules. For the specific congeners mentioned in this table, the Ballschmiter-Zell numbers correspond to those of Schulte and 
Malisch. When two or more congeners are known to coelute under the GC analysis conditions used, the PCB congener listed first is the major 
component and the additional congeners may be present as minor components
b
Values are weighted means of the mass fractions determined by two to five analytical methods [29]. The uncertainty listed with each value is an 
expanded uncertainty about the mean [29, 35], with coverage factor, k = 2 (except k = 4 for PCB 180/193 in SRM 1957), calculated by combining a 
pooled within method variance with a between method variance [29, 36] following the ISO Guide [37, 38]
c
Values are the means of results using one analytical technique. The expanded uncertainty, U, is calculated as U = kuc, where uc is one standard 
deviation of the analyte mean, and the coverage factor, k, is determined from the Student's t-distribution corresponding to the associated degrees of 
freedom and 95 % confidence level for each analyte
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Table 2
Certified, Reference, and Information mass fractions (ng/kg milk or reconstituted serum) of selected 
pesticides in SRM 1953 organic contaminants in non-fortified human milk, SRM 1954 organic contaminants 
in fortified human milk, SRM 1957 organic contaminants in non-fortified human serum, and SRM 1958 
organic contaminants in fortified human serum







Hexachlorobenzene 261±30a 671±48a 29.7±3.5a 442±46a
Octachlorostyrene 374±28b 359±19a
α-HCH 260±44a
β-HCH 610±4a 820±6a 31.3±6.0a 278±47a
γ-HCH 587±54a 315±43a
Oxychlordane 612±68a 1060±150a 226±43a
cis-Chlordane 368±9a 412±25a
trans-Chlordane 378±7a 412±3a
cis-Nonachlor 126±6a 499±5a 425±23a
trans-Nonachlor 1240±70a 1690±110a 58.3±1.9a 469±6a
Mirex 68±25a 512±7a 384±59a
2,4′-DDE 403±6a 450±20a
4,4′-DDE 7430±420a 8150±200a 921±76a 1250±130a
2,4′-DDD 421±7a 347±46a
4,4′-DDD 422±8a 416±17a
2,4′-DDT 18.2±1.2b 443±9a 313±43a
4,4′-DDT 229±16a 691±37a 293±12a
2-endo,3-exo,5-endo,6-exo,8,8,10,10-octachlorobornane (Parlar 26) 340
2-endo,3-exo,5-endo,6-exo,8,8,9,10,10-nonachlorobornane (Parlar 50) 230
2,2,5,5,8,9,9,10,10-nonachlorobornane (Parlar 62) 320
a
Values are weighted means of the mass fractions determined by two to five analytical methods [29]. The uncertainty listed with each value is an 
expanded uncertainty about the mean [29, 35], with coverage factor, k = 2, calculated by combining a pooled within method variance with a 
between method variance [29, 36] following the ISO Guide [37, 38]
b
Values are the means of results using one analytical technique. The expanded uncertainty, U, is calculated as U = kuc, where uc is one standard 
deviation of the analyte mean, and the coverage factor, k, is determined from the Student's t-distribution corresponding to the associated degrees of 
freedom and 95 % confidence level for each analyte
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Table 3
Certified and Reference mass fractions (ng/kg milk or reconstituted serum) of selected PBDE congeners and 
PBB 153 in SRM 1953 organic contaminants in non-fortified human milk, SRM 1954 organic contaminants in 
fortified human milk, SRM 1957 organic contaminants in non-fortified human serum, and SRM 1958 organic 
contaminants in fortified human serum
PBDE congenera SRM 1953 SRM 1954 SRM 1957 SRM 1958
PBDE 17 16.8±0.1b 401 ±50b 4.2±1.5b 458±32b
PBDE 28 137±18b 576±7b 20.0±2.4b 462 ±19b
PBDE 47 2240±30b 2590±80b 268±14b 651 ±29b
PBDE 66 16.2±3.4b 414±10b 6.70±0.13b 440±41b
PBDE 85 49.2±8.1b 475 ±22b 8.2±1.9b 475 ±39b
PBDE 99 341±8b 738±47b 76.0±3.8b 492±15b
PBDE 100 822±15b 1280±40b 49.7±2.7b 475 ±27b
PBDE 153 971 ±23b 1440±100b 61.0±3.2b 455±54b
PBDE 154 42.7±2.3b 470 ±13b 7.0±1.0c 441 ±39b
PBDE 183 507±43b 453±42b
PBDE 203 494±44c
PBDE 206 820±280b 426±4b
PBDE 209 423±24b 417±5b
PBB 153 36.5±0.6b 476±9b 15.5±0.1b 421±13b
a
PBDE congeners and PBB 153 are numbered according to IUPAC rules
b
Values are weighted means of the mass fractions determined by two to five analytical methods [29]. The uncertainty listed with each value is an 
expanded uncertainty about the mean [29, 35], with coverage factor, k = 2 (except k = 4 for PBDE 206 in SRM 1958), calculated by combining a 
pooled within method variance with a between method variance [29, 36] following the ISO Guide [37, 38]
c
Values are the means of results using one analytical technique. The expanded uncertainty, U, is calculated as U = kuc, where uc is one standard 
deviation of the analyte mean, and the coverage factor, k, is determined from the Student's t-distribution corresponding to the associated degrees of 
freedom and 95 % confidence level for each analyte
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Table 4
Reference mass fractions (pg/kg milk or reconstituted serum) of selected PCDD and PCDF congeners in SRM 
1953 organic contaminants in non-fortified human milk, SRM 1954 organic contaminants in fortified human 
milk, SRM 1957 organic contaminants in non-fortified human serum, and SRM 1958 organic contaminants in 
fortified human serum
Dioxin or furan congenera SRM 1953 SRM 1954 SRM 1957 SRM 1958
2,3,7,8-TCDD 55.2±4.6a 162±32a 94.2±7.8a
1,2,3,7,8-PCDD 123±11a 240±27a 17.3±2.9a 106 ± 12a
1,2,3,4,7,8-HxCDD 77.7±9.0a 180±21a 11.8±1.7a 95.3±9.9a
1,2,3,6,7,8-HxCDD 501±91a 890±240a 82±18a 340±60a
1,2,3,7,8,9-HxCDD 100±11a 206±33a 18.7±0.3a 99.6±7.2a
1,2,3,4,6,7,8-HpCDD 480±160a 1080±410a 104±36a 565±90a
OCDD 2240±360a 4890±1430a 716±81a 2570±280a
2,3,7,8-TCDF 16.4±0.6a 125±13a 104±3a
1,2,3,7,8-PCDF 132±29a 98±15a
2,3,4,7,8-PCDF 127±11a 344±33a 16.4±2.5a 199±30a
1,2,3,4,7,8-HxCDF 72±10a 171±22a 17.0±3.1a 95.9±9.3a
1,2,3,6,7,8- HxCDF 66.0±1.3a 183±20a 14.1±2.5a 102±11a
1,2,3,7,8,9- HxCDF 31.6±0.8a 126±9a 94±11a
2,3,4,6,7,8- HxCDF 1080±160a 900±110a
1,2,3,4,6,7,8-HpCDF 100±12a 405±66a 39.8±6.2a 289±9a
1,2,3,4,7,8,9-HpCDF 84±12a
OCDF 11.6±5.0b 94.3±12.7b 83.3±1.7a
a
Values are weighted means of the mass fractions determined by two to three analytical methods [29]. The uncertainty listed with each value is an 
expanded uncertainty about the mean [29, 35], with coverage factor, k = 2, calculated by combining a pooled within method variance with a 
between method variance [29, 36] following the ISO Guide [37, 38]
b
Values are the means of results using one analytical technique. The expanded uncertainty, U, is calculated as U = kuc, where uc is one standard 
deviation of the analyte mean, and the coverage factor, k, is determined from the Student's t-distribution corresponding to the associated degrees of 
freedom and 95 % confidence level for each analyte
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